Temporary or definitive suspensions of clinical trials upon notifications from the Clinical Trials Vigilance Unit of Rennes University Hospital

被引：0
|
作者：
Lefeuvre, C. [1 ]
Mouchel, C. [1 ]
Prioul, A. [1 ]
Polard, E. [1 ]
Bellissant, E. [1 ]
Laviolle, B. [1 ]
机构：
[1] Rennes Univ Hosp, INSERM, Dept Clin Pharmacol, Rennes, France
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2022年 / 36卷
关键词：
clinical trial; temporary suspension; definitive suspension; risk-benefit balance; Data Safety Monitoring Board;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PS-038
引用
收藏
页码：112 / 112
页数：1
相关论文
共 50 条
  • [21] IMPACT OF CLINICAL-TRIALS ON THE ADOPTION OF NEW DRUGS WITHIN A UNIVERSITY HOSPITAL
    DENIG, P
    HAAIJER-RUSKAMP, FM
    WESSELING, H
    VERSLUIS, A
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 41 (04) : 325 - 328
  • [22] National Center of Excellence for Clinical Trials and Research at National Taiwan University Hospital
    Lin, Chia-Chi
    Yang, Chih-Hsin
    Cheng, Ann-Lii
    Chan, Wing-Kai
    Ho, Hong-Nerng
    DRUG INFORMATION JOURNAL, 2009, 43 (03): : 361 - 363
  • [23] Quantitative and qualitative evaluations of data of serious adverse events reported to the vigilance unit during clinical trials
    Aydin, D.
    Blanc, E.
    Nguon, M.
    Robinson, P.
    Bodenan, E.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2019, 33 : 83 - 83
  • [24] Cross-site audits of clinical trials vigilance departments in 6 university hospitals in Western France
    Mouchel, C.
    Boivin, H.
    Carlhant-Kowalski, D.
    Chiffoleau, A.
    Duranton, S.
    Jamet, A.
    Bellissant, E.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2014, 28 : 65 - 65
  • [25] DESIGN OF A PROACTIVE PROGRAM FOR THE RATIONAL USE OF PLASTIC FROM CLINICAL TRIALS IN LA PAZ UNIVERSITY HOSPITAL
    Cebanu, T.
    Garcia-Barcenilla, S.
    Monzon-Manzano, E.
    Fernandez-Bello, I.
    Alvarez-Roman, M. T.
    Martin-Salces, M.
    Rivas-Pollmar, I.
    Acuna-Butta, P.
    Butta-Coll, N.
    Jimenez-Yuste, V.
    HAEMOPHILIA, 2020, 26 : 37 - 38
  • [26] ISO 9001 certification process in clinical trials: contribution of quality tools to the safety management system in a vigilance unit
    Rousset, L.
    Mollard, M.
    Bodenan, E.
    Robinson, P.
    Blanc, E.
    Nguon, M.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2019, 33 : 40 - 40
  • [27] An international survey of physicians regarding clinical trials: a comparison between Kyoto University Hospital and Seoul National University Hospital
    Toshiko Ito-Ihara
    Jeong-Hwa Hong
    Ock-Joo Kim
    Eriko Sumi
    Soo-Youn Kim
    Shiro Tanaka
    Keiichi Narita
    Taichi Hatta
    Eun-Kyung Choi
    Kyu-Jin Choi
    Takuya Miyagawa
    Manabu Minami
    Toshinori Murayama
    Masayuki Yokode
    BMC Medical Research Methodology, 13
  • [28] An international survey of physicians regarding clinical trials: a comparison between Kyoto University Hospital and Seoul National University Hospital
    Ito-Ihara, Toshiko
    Hong, Jeong-Hwa
    Kim, Ock-Joo
    Sumi, Eriko
    Kim, Soo-Youn
    Tanaka, Shiro
    Narita, Keiichi
    Hatta, Taichi
    Choi, Eun-Kyung
    Choi, Kyu-Jin
    Miyagawa, Takuya
    Minami, Manabu
    Murayama, Toshinori
    Yokode, Masayuki
    BMC MEDICAL RESEARCH METHODOLOGY, 2013, 13
  • [29] Accrual to breast cancer clinical trials at a university-affiliated hospital in metropolitan Detroit
    Simon, MS
    Brown, DR
    Du, W
    LoRusso, P
    Kellogg, CM
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1999, 22 (01): : 42 - 46
  • [30] Clinical trials for drug approval : a pilot study of the view of doctors at Tokushima University Hospital
    Yanagawa, Hiroaki
    Nishiya, Masako
    Miyamoto, Toshiko
    Shikishima, Michiyo
    Imura, Mitsuko
    Nakanishi, Rika
    Ariuchi, Kazuyo
    Akaishi, Akiyo
    Takai, Shigemi
    Abe, Shinji
    Kisyuku, Masatoshi
    Kageyama, Chieko
    Sato, Chiho
    Yamagami, Makiko
    Urakawa, Noriko
    Sone, Saburo
    Irahara, Minoru
    JOURNAL OF MEDICAL INVESTIGATION, 2006, 53 (3-4): : 292 - 296
12345